Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen‐specific CD8+ T‐cell response and inhibits the PSCA+ tumors growth in mice
Authors:
- 27 June 2007
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 9 (8) , 715-726
Abstract
Background: DNA vaccines have been shown to be an effective approach to induce antigen‐specific cellular and humoral immunity. However, the lower immune intensity in clinical trials limits the application of DNA vaccine. Here we intend to develop a new DNA vaccine based on prostate stem‐cell antigen (PSCA), which has been suggested as a potential target for prostate cancer therapy, and enhance the DNA vaccine potency with heat shock proteins (HSPs) as adjuvant.Methods: A series of DNA plasmids encoding human PSCA, human HSP70 and their conjugates was constructed and injected into male mice intramuscularly (i.m.). To evaluate the immune responses and therapeutic efficacy of these plasmids, major histocompatibility complex (MHC)‐restricted PSCA and HSP70‐specific epitopes were predicted and a mouse model with a human PSCA‐expressing tumor was constructed.Results: The result showed that mice vaccinated with PSCA‐HSP plasmids generated the strongest PSCA‐specific CD8+ T‐cell immune response, but the CD4+ TH1 and TH2 cell immune responses were similar with those vaccinated with other HSP‐adjuvant PSCA plasmids or only PSCA DNA. The immunity of HSP70 was also observed and the mice i.m. injected with PSCA+ HSP mixed plasmids generated the lowest anti‐HSP antibodies. Furthermore, these vaccinations inhibited the growth of PSCA‐expressing tumors and prolonged mouse survival.Conclusions: These observations emphasize and extend the potential of the human HSP70 gene as adjuvant for DNA vaccines, and the vaccine based on PSCA and HSP70 is of potential value for treating prostate cancer. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cellsEuropean Journal of Immunology, 2005
- Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral ?blips?Vaccine, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Prediction of Promiscuous and High-Affinity Mutated MHC BindersHybridoma and Hybridomics, 2003
- Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancerOncogene, 2000
- Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccineOncogene, 1998
- Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumorsSeminars in Cancer Biology, 1995
- A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primateInternational Journal of Cancer, 1995
- Heat shock proteins in immune response to cancer: The Fourth ParadigmCellular and Molecular Life Sciences, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993